Ask your MP to represent you
Ask your MP to represent you by contacting them using this template letter to ask them to sign two cross-party letters to Matt Hancock, Secretary of State for Health and Social Care, and Jeff Leiden, Chief Executive of Vertex Pharmaceuticals. MPs must contact Ian Austin, MP for Dudley North, before Friday 26 July to sign these letters, so be sure to get in contact with your MP as soon as possible.
Download the template letter
Health and Social Care Committee
On Tuesday 9 July David Ramsden, Chief Executive at the Trust, met with key supportive MPs at a roundtable event in Westminster, hosted by Ian Austin MP. All present committed to increasing the pressure on Vertex and the Government to urgently find a positive solution. Dr Sarah Wollaston, Chair of the Health and Social Care Committee, also quizzed Matt Hancock in an evidence session that afternoon.
The Cystic Fibrosis Trust understands that NHS England and the company, Vertex Pharmaceuticals, continue to meet to discuss access to the drugs. However, no timetable has been set for an outcome.
In early July, Matt Hancock MP, Secretary of State for Health and Social Care, met with Carlie Pleasant as she attended King’s College Hospital for her CF care. They discussed the campaign for access to life-saving drugs and Mr Hancock told Carlie, “be assured, we’re on this and are committed to achieving a resolution for all those battling CF across the UK.” Carlie told followers on social media, “I genuinely feel our Health Minister has our best interests at heart.”
Letters to the future Prime Minister
With a new Conservative Party leader and UK Prime Minister due to be chosen imminently, David Ramsden wrote to both Jeremy Hunt and Boris Johnson to prioritise getting a deal done for CF drugs. We received this response from Jeremy Hunt and await a response from Boris Johnson.
Last month, Valerie Watts, Chief Executive of Northern Ireland’s Health and Social Care Board, in correspondence with David Ramsden, has outlined that the Board could follow guidance from the SMC, in the absence of guidance from NICE, making the outcome of the meeting of the SMC last week an important milestone for people with CF in both Scotland and Northern Ireland.
In early July, the Scottish Medicines Consortium (SMC) met to discuss access to Orkambi and Symkevi in Scotland. Their recommendations are due to be announced in mid-August and will guide NHS Scotland’s approach to prescribing these life-saving drugs.
The National Assembly for Wales’ Petitions Committee met on 9 July, where evidence from Vertex Pharmaceuticals was heard that stated an intention to submit Orkambi and Symkevi for independent review with the All Wales Medicines Strategy Group.
For the latest news on our Stopping the Clock campaign and other updates in the CF community, sign up to receive our e-newsletter.